Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
04/18/2024 | ARK INVESTMENT MANAGEMENT LLC | 8.16 M | $555.98 M | -4.44% | 9.97% |
05/14/2024 | CAPITAL INTERNATIONAL INVESTORS | 7.84 M | $534.17 M | 27.76% | 9.58% |
04/19/2024 | SUMITOMO MITSUI TRUST HOLDINGS, INC. | 3.27 M | $222.80 M | -3.00% | 4.00% |
05/02/2024 | NIKKO ASSET MANAGEMENT AMERICAS, INC. | 3.27 M | $222.70 M | -3.00% | 4.00% |
05/15/2024 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 2.70 M | $184.33 M | -25.11% | 3.31% |
05/10/2024 | BLACKROCK INC. | 2.55 M | $173.56 M | 1.19% | 3.21% |
05/13/2024 | FMR LLC | 2.24 M | $152.66 M | 21.73% | 2.83% |
05/10/2024 | VANGUARD GROUP INC | 1.64 M | $111.56 M | 2.90% | 2.07% |
05/15/2024 | NEA MANAGEMENT COMPANY, LLC | 1.59 M | $180.41 M | 0.00% | 1.94% |
05/15/2024 | STATE STREET CORP | 1.50 M | $101.91 M | -14.73% | 1.89% |
05/15/2024 | ECOR1 CAPITAL, LLC | 1.39 M | $94.69 M | 100.00% | 1.70% |
05/15/2024 | MORGAN STANLEY | 1.09 M | $74.02 M | 162.89% | 1.37% |
05/13/2024 | SR ONE CAPITAL MANAGEMENT, LP | 1.05 M | $71.50 M | 100.00% | 1.28% |
05/14/2024 | LOOMIS SAYLES & CO L P | 1.03 M | $69.88 M | -3.95% | 1.25% |
05/10/2024 | DIMENSIONAL FUND ADVISORS LP | 931,055 | $63.46 M | 19.45% | 1.18% |
05/13/2024 | GEODE CAPITAL MANAGEMENT, LLC | 909,298 | $62.00 M | 2.89% | 1.15% |
05/15/2024 | BANK OF AMERICA CORP /DE/ | 863,214 | $58.84 M | 24.89% | 1.09% |
05/15/2024 | CITADEL ADVISORS LLC | 835,100 | $56.92 M | -27.41% | 1.05% |
05/07/2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 731,200 | $49.84 M | -19.97% | 0.92% |
05/10/2024 | CREDIT SUISSE AG/ | 719,309 | $49.03 M | -17.90% | 0.91% |
05/09/2024 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 669,192 | $45.61 M | 2.48% | 0.84% |
05/10/2024 | CONTRARIUS INVESTMENT MANAGEMENT LTD | 666,000 | $45.40 M | 264.08% | 0.81% |
05/15/2024 | BELLEVUE GROUP AG | 619,950 | $42.26 M | -31.15% | 0.76% |
05/15/2024 | PRICE T ROWE ASSOCIATES INC /MD/ | 600,234 | $40.91 M | -30.56% | 0.76% |
05/07/2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 565,500 | $38.54 M | 27.85% | 0.71% |
05/15/2024 | CITADEL ADVISORS LLC | 485,400 | $33.08 M | -30.63% | 0.61% |
05/03/2024 | VERSANT VENTURE MANAGEMENT, LLC | 498,558 | $33.98 M | 0.00% | 0.61% |
05/14/2024 | FEDERATED HERMES, INC. | 447,606 | $30.51 M | -11.91% | 0.57% |
05/15/2024 | AVORO CAPITAL ADVISORS LLC | 419,580 | $28.60 M | 100.00% | 0.51% |
05/10/2024 | JPMORGAN CHASE & CO | 392,750 | $26.77 M | -15.22% | 0.50% |
05/01/2024 | BAILLIE GIFFORD & CO | 395,915 | $26.99 M | -6.35% | 0.48% |
05/15/2024 | CAPTION MANAGEMENT, LLC | 385,000 | $26.24 M | -33.70% | 0.47% |
05/13/2024 | UBS GROUP AG | 320,377 | $21.84 M | 3.05% | 0.40% |
05/14/2024 | PICTET ASSET MANAGEMENT HOLDING SA | 320,523 | $22.16 M | 3,595.22% | 0.39% |
05/15/2024 | CAPTION MANAGEMENT, LLC | 295,000 | $20.11 M | -26.25% | 0.36% |
05/14/2024 | PEAK6 INVESTMENTS LLC | 288,100 | $19.64 M | 1,180.44% | 0.35% |
05/15/2024 | SQUAREPOINT OPS LLC | 274,030 | $18.68 M | 115.17% | 0.34% |
05/15/2024 | BARCLAYS PLC | 256,331 | $17.47 M | -18.10% | 0.32% |
04/29/2024 | CAPITAL ADVISORS INC/OK | 263,986 | $17.99 M | 3.42% | 0.32% |
05/14/2024 | NORTHERN TRUST CORP | 243,278 | $16.58 M | -2.86% | 0.31% |
05/15/2024 | VESTMARK ADVISORY SOLUTIONS, INC. | 249,544 | $17.01 M | 44.01% | 0.31% |
05/15/2024 | CITADEL ADVISORS LLC | 237,100 | $16.16 M | -13.26% | 0.30% |
05/15/2024 | D. E. SHAW & CO., INC. | 218,500 | $14.89 M | 35.80% | 0.28% |
05/10/2024 | WELLS FARGO & COMPANY/MN | 216,394 | $14.75 M | 28.50% | 0.27% |
05/15/2024 | INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 220,000 | $15.00 M | 100.00% | 0.27% |
05/14/2024 | EAGLE HEALTH INVESTMENTS LP | 197,000 | $13.43 M | 100.00% | 0.24% |
05/15/2024 | ARMISTICE CAPITAL, LLC | 192,000 | $13.09 M | 14.29% | 0.23% |
05/15/2024 | CAPITAL FUND MANAGEMENT S.A. | 188,500 | $12.85 M | 789.15% | 0.23% |
05/16/2024 | JANE STREET GROUP, LLC | 175,072 | $11.93 M | -63.14% | 0.22% |
05/15/2024 | D. E. SHAW & CO., INC. | 174,295 | $11.88 M | 367.63% | 0.22% |
A. During the previous two years, 630 institutional investors and hedge funds held shares of CRISPR Therapeutics AG. The most heavily invested institutionals were:
ARK Investment Management LLC: 8.16 M
Capital International Investors: 7.84 M
Sumitomo Mitsui Trust Holdings, Inc.: 3.27 M
Nikko Asset Management Americas, Inc.: 3.27 M
T. Rowe Price Investment Management, Inc.: 2.7 M
BlackRock Inc.: 2.55 M
A. 71.52% of CRISPR Therapeutics AG stock is owned by institutional investors.
A. Institutional investors have bought a total of 68.33 M shares in the last 24 months. This purchase volume represents approximately $3.63 B in transactions.